The present invention relates to (lR,5S)-(+)-l-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane and pharmaceutical compositions thereof, and methods employing their use in the treatment of conditions affected by monoamine neurotransmitters, including ADHD and substance abuse.
本发明涉及(lR,5S)-(+)-1-(
萘基)-
3-氮杂双环[3.1.0]己烷及其制药组合物,以及使用它们治疗受单胺神经递质影响的疾病,包括注意力缺陷多动障碍和物质滥用的方法。